Innova Captab Ltd (INNC)

NSE
Currency in INR
869.85
+7.45(+0.86%)
Closed·
INNC Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
INNC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
850.60873.00
52 wk Range
495.601,260.00
Key Statistics
Edit
Bid/Ask
867.10 / 869.80
Prev. Close
862.4
Open
865
Day's Range
850.6-873
52 wk Range
495.6-1,260
Volume
54.51K
Average Volume (3m)
77.83K
1-Year Change
68.17%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
INNC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,091.00
Upside
+25.42%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Innova Captab Company Profile

Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also involved in the development, manufacture, and distribution of generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through its network of distributors and pharmacies, as well as online through various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.

Employees
1600
Market
India

Compare INNC to Peers and Sector

Metrics to compare
INNC
Peers
Sector
Relationship
P/E Ratio
38.5x26.7x−0.5x
PEG Ratio
1.910.850.00
Price/Book
5.1x4.8x2.6x
Price / LTM Sales
4.0x4.0x3.1x
Upside (Analyst Target)
26.5%5.3%47.8%
Fair Value Upside
Unlock1.7%6.9%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,091.00
(+25.42% Upside)

Earnings

Latest Release
May 19, 2025
EPS / Forecast
5.17 / --
Revenue / Forecast
3.12B / --
EPS Revisions
Last 90 days

INNC Income Statement

FAQ

What Is the Innova Captab (INNC) Stock Price Today?

The Innova Captab stock price today is 869.85.

What Stock Exchange Does Innova Captab Trade On?

Innova Captab is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Innova Captab?

The stock symbol for Innova Captab is "INNC."

What Is the Innova Captab Market Cap?

As of today, Innova Captab market cap is 49.35B.

What Is Innova Captab's Earnings Per Share (TTM)?

The Innova Captab EPS (TTM) is 22.41.

When Is the Next Innova Captab Earnings Date?

Innova Captab will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is INNC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Innova Captab Stock Split?

Innova Captab has split 0 times.

How Many Employees Does Innova Captab Have?

Innova Captab has 1600 employees.

What is the current trading status of Innova Captab (INNC)?

As of 09 Jul 2025, Innova Captab (INNC) is trading at a price of 869.85, with a previous close of 862.40. The stock has fluctuated within a day range of 850.60 to 873.00, while its 52-week range spans from 495.60 to 1,260.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.